(VIANEWS) – AUSTEVOLL SEAFOOD (AUSS.OL), TOTENS SPAREBANK (TOTG.OL), EDP (EDP.LS) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| AUSTEVOLL SEAFOOD (AUSS.OL) | 7.18% | 2024-10-10 08:24:44 |
| TOTENS SPAREBANK (TOTG.OL) | 5.5% | 2024-10-10 08:43:55 |
| EDP (EDP.LS) | 4.73% | 2024-10-10 08:23:04 |
| SANOFI (SAN.PA) | 3.7% | 2024-10-06 12:02:05 |
| NOVABASE,SGPS (NBA.LS) | 2.26% | 2024-10-10 08:23:39 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. AUSTEVOLL SEAFOOD (AUSS.OL)
7.18% Foward Dividend Yield
AUSTEVOLL SEAFOOD’s last close was kr100.10, 16.02% under its 52-week high of kr119.20. Intraday change was 1.99%.
Austevoll Seafood ASA, a seafood company, engages in the production of salmon and trout, white fish, and pelagic in Norway, the European Union, the United Kingdom, Eastern Europe, Africa, North America, Asia, and South America. The company is involved in the ownership and operation of fishing vessels; and sale and distribution of different fish species and processed fish products. It also produces white fish products, fish meals, and fish oils; omega-3 oil; and canned and frozen fish products. The company was incorporated in 1981 and is headquartered in Storebø, Norway. Austevoll Seafood ASA is a subsidiary of Laco AS.
Earnings Per Share
As for profitability, AUSTEVOLL SEAFOOD has a trailing twelve months EPS of kr8.65.
PE Ratio
AUSTEVOLL SEAFOOD has a trailing twelve months price to earnings ratio of 11.55. Meaning, the purchaser of the share is investing kr11.55 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.89%.
Moving Average
AUSTEVOLL SEAFOOD’s worth is way above its 50-day moving average of kr74.99 and way above its 200-day moving average of kr85.76.
Sales Growth
AUSTEVOLL SEAFOOD’s sales growth for the next quarter is negative 1.7%.
More news about AUSTEVOLL SEAFOOD.
2. TOTENS SPAREBANK (TOTG.OL)
5.5% Foward Dividend Yield
TOTENS SPAREBANK’s last close was kr262.00, 2.84% below its 52-week high of kr269.65. Intraday change was 0%.
Totens Sparebank provides various banking and financial products and services in Norway. The company offers savings and pension products; mortgage, car, other vehicle, business, and construction loans; small loans; leasing; overdrafts and bank guarantees; home, leisure, car and other vehicle, animal, company and employee, agriculture, business, data attack, property damage, craftsman, health, landlord, collective, personnel, travel, and occupational injury insurance; and business and credit cards. It also provides online and mobile banking services; and payment solutions. Totens Sparebank was founded in 1854 and is headquartered in Lena, Norway.
Earnings Per Share
As for profitability, TOTENS SPAREBANK has a trailing twelve months EPS of kr22.35.
PE Ratio
TOTENS SPAREBANK has a trailing twelve months price to earnings ratio of 11.72. Meaning, the purchaser of the share is investing kr11.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.15%.
Yearly Top and Bottom Value
TOTENS SPAREBANK’s stock is valued at kr262.00 at 07:50 EST, below its 52-week high of kr269.65 and way higher than its 52-week low of kr186.00.
More news about TOTENS SPAREBANK.
3. EDP (EDP.LS)
4.73% Foward Dividend Yield
EDP’s last close was €3.86, 16.8% below its 52-week high of €4.64. Intraday change was -0.31%.
EDP, S.A. engages in the generation, transmission, distribution, and supply of electricity in Portugal, Spain, France, Poland, Romania, Italy, Belgium, the United Kingdom, Greece, Colombia, Brazil, North America, and internationally. It operates through Renewables, Networks, and Client Solutions & Energy Management segments. The company primarily generates and sells electricity through hydro, CCGT, coal, wind, solar, nuclear, and cogeneration and waste sources. It has an installed capacity of 28 GW; and operates 380,788 kilometers of distribution network lines. The company is also involved in the supply of natural gas. In addition, it offers engineering, laboratory tests, professional training, and energy services, as well as property management services. The company's electricity and gas customers include domestic, industrial, commercial, agricultural, and others. The company was formerly known as EDP – Energias de Portugal, S.A. and changed its name to EDP, S.A. in April 2024. The company was incorporated in 1976 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, EDP has a trailing twelve months EPS of €0.3.
PE Ratio
EDP has a trailing twelve months price to earnings ratio of 12.96. Meaning, the purchaser of the share is investing €12.96 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.76%.
Volume
Today’s last reported volume for EDP is 1492040 which is 77.9% below its average volume of 6751690.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EDP’s stock is considered to be overbought (>=80).
More news about EDP.
4. SANOFI (SAN.PA)
3.7% Foward Dividend Yield
SANOFI’s last close was €100.60, 5.22% under its 52-week high of €106.14. Intraday change was -0.87%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 07:50 EST, way below its 52-week high of €106.14 and way above its 52-week low of €80.60.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 47.08B for the twelve trailing months.
More news about SANOFI.
5. NOVABASE,SGPS (NBA.LS)
2.26% Foward Dividend Yield
NOVABASE,SGPS’s last close was €5.80, 7.93% higher than its 52-week high of €5.37. Intraday change was 0%.
Novabase S.G.P.S., S.A., through its subsidiaries, provides IT consulting and services in Portugal, rest of Europe, Africa, the Middle East, and internationally. It operates through two segments, Next-Gen and Value Portfolio. The Next-Gen segment develops IT consulting and services to banks, insurance, capital markets, and telecommunication industries under the Celfocus brand name. The Value Portfolio segment is involved in venture capital activities. Novabase S.G.P.S., S.A. was incorporated in 1989 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, NOVABASE,SGPS has a trailing twelve months EPS of €0.12.
PE Ratio
NOVABASE,SGPS has a trailing twelve months price to earnings ratio of 48.33. Meaning, the purchaser of the share is investing €48.33 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.
Moving Average
NOVABASE,SGPS’s value is way above its 50-day moving average of €4.62 and way above its 200-day moving average of €4.68.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 176.23M for the twelve trailing months.
More news about NOVABASE,SGPS.
